Today men with prostate cancer have larger prostates

Urology

Volumn 56, Issue 5, 2000, Pages 839-842

  Feneley, Mark R ^a   Landis, Patricia ^a   Simon, Inpakala ^a   Metter, E Jeffrey ^b   Morrell, Christopher H ^c   Carter, H Ballentine ^a   Walsh, Patrick C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c LOYOLA UNIVERSITY MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY;

ADULT; AGED; AGING; COMPARATIVE STUDY; HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGE; NEOPLASM STAGING; ORGAN WEIGHT; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0033782983     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00738-X     Document Type: Article

References (7)

1. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia
2. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
3. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia
4. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography
5. Early detection of prostate cancer; Serendipity strikes again
6. 3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer